Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome
Lundin, Jeanette, Hagberg, Hans, Repp, Roland, Cavallin-Ståhl, Eva, Fredén, Susanne, Juliusson, Gunnar, Rosenblad, Eija, Tjønnfjord, Geir, Wiklund, Tom, Österborg, Anders
Published in Blood (01.06.2003)
Published in Blood (01.06.2003)
Get full text
Journal Article
Gastric Bypass Promotes More Lipid Mobilization Than a Similar Weight Loss Induced by Low-Calorie Diet
Kullberg, Joel, Sundbom, Magnus, Haenni, Arvo, Freden, Susanne, Johansson, Lars, Börnert, Peter, Ahlström, Anders, Ahlström, Håkan, Karlsson, Anders
Published in Journal of Obesity (01.01.2011)
Published in Journal of Obesity (01.01.2011)
Get full text
Journal Article
Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
ANDERSEN, Niels S, PEDERSEN, Lone B, NORDSTRÖM, Marie, FREDEN, Susanne, JERKEMAN, Mats, ERIKSSON, Mikael, VÄÄRT, Jaan, MALMER, Beatrice, GEISLER, Christian H, LAURELL, Anna, ELONEN, Erkki, KOLSTAD, Arne, BOESEN, Anne Marie, PEDERSEN, Lars M, LAURITZSEN, Grete F, EKANGER, Roald, NILSSON-EHLE, Herman
Published in Journal of clinical oncology (10.09.2009)
Published in Journal of clinical oncology (10.09.2009)
Get full text
Journal Article
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur
Geisler, Christian H., Kolstad, Arne, Laurell, Anna, Jerkeman, Mats, Räty, Riikka, Andersen, Niels S., Pedersen, Lone B., Eriksson, Mikael, Nordström, Marie, Kimby, Eva, Bentzen, Hans, Kuittinen, Outi, Lauritzsen, Grete F., Nilsson-Ehle, Herman, Ralfkiær, Elisabeth, Ehinger, Mats, Sundström, Christer, Delabie, Jan, Karjalainen-Lindsberg, Marja-Liisa, Brown, Peter, Elonen, Erkki
Published in British journal of haematology (01.08.2012)
Published in British journal of haematology (01.08.2012)
Get full text
Journal Article
Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome
Lundin, Jeanette, Hagberg, Hans, Repp, Roland, Cavallin-Ståhl, Eva, Fredén, Susanne, Juliusson, Gunnar, Rosenblad, Eija, Tjønnfjord, Geir, Wiklund, Tom, Österborg, Anders
Published in Blood (01.06.2003)
Published in Blood (01.06.2003)
Get full text
Journal Article